Related Experiment Videos
Buspirone: effects on prolactin and growth hormone as a function of drug level in generalized anxiety
Journal of Clinical Psychopharmacology
|October 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The double-blind variable placebo lead-in period: results from two antidepressant clinical trials.
Journal of clinical psychopharmacology·2002
Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.
The Journal of clinical psychiatry·2001
Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.
The Journal of clinical psychiatry·2001
Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone.
The Journal of clinical psychiatry·2001
No gender differences in placebo responses of patients with major depressive disorder.
Biological psychiatry·2001
Single-Dose Ayahuasca for Depressive and Anxiety Symptoms Associated With Cancer Diagnosis: A Single-Blind Feasibility Proof-of-Concept Trial.
Journal of clinical psychopharmacology·2026
Low-Dose Clozapine Versus Aripiprazole in Borderline Personality Disorder: A Prospective Naturalistic Study.
Journal of clinical psychopharmacology·2026
Efficacy and Tolerability of Zonisamide for Alcohol Use Disorder: A Systematic Review and Meta-Analysis.
Journal of clinical psychopharmacology·2026
The Antidepressant Effects of the mGlu2/3 Receptor Antagonist TS-161 in Treatment-Resistant Depression: A Phase IIa Proof-of-Concept Clinical Trial.
Journal of clinical psychopharmacology·2026
The Randomization Effect in a Double-Blind Placebo-Controlled Depression Study.
Journal of clinical psychopharmacology·2026
Memantine Augmentation for Obsessive-Compulsive Symptoms in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
Journal of clinical psychopharmacology·2026
Cannabinoid modulation of central amygdala population dynamics during threat investigation.
Nature communications·2026
Development and assessment of an artificial intelligence-based tool for scoring lesion severity in generalized pustular psoriasis clinical images.
JID innovations : skin science from molecules to population health·2026
Prevalence and Correlates of Symptoms of Cannabinoid Hyperemesis Syndrome in the United States, 2025.
American journal of public health·2026